HIMS Stock: New Testosterone Push Builds as GLP-1 Market Crowds

Hims & Hers Health, Inc. (HIMS) has strategically expanded its testosterone-care offerings with the introduction of Testosterone Rx+. This move comes as the competitive landscape in the GLP-1 weight-loss market intensifies, with major players like Novo Nordisk and Eli Lilly scaling their blockbuster therapies. Additionally, regulatory changes, such as the FDA's proposed restrictions on compounding GLP-1 ingredients like Semaglutide and Tirzepatide, could limit the availability of compounded versions, making Hims' diversification efforts crucial.

Testosterone Rx+ combines Enclomiphene with zinc, vitamins B6 and B12, and L-arginine. Company data indicates that 95% of users experienced increased testosterone levels, with 80% reaching optimal levels within 60 days. This program includes symptom-screening tools, at-home lab testing kits, and virtual care through the Hims platform.

The FDA's encouragement for sponsors of approved testosterone replacement therapies to explore new indications for treating low libido from idiopathic hypogonadism further supports Hims' expansion. Hims began building its testosterone platform in September 2025, offering Enclomiphene-based treatments and combination therapy with Tadalafil for men with low testosterone.

While HIMS stock has declined 18% over the past year, recent developments and positive user data suggest a potential turnaround. However, retail trader sentiment on Stocktwits remains bearish amid low message volume.

It is a once-daily pill from Hims designed to help the body naturally increase testosterone levels, combining Enclomiphene with other supplements.

According to company data, 95% of users saw increases in testosterone levels, with 80% reaching optimal levels within 60 days.

Due to increasing competition in the GLP-1 weight-loss market and potential FDA restrictions on compounded GLP-1 ingredients.

Do you think Hims' focus on testosterone therapies will be a successful strategy? Share this article with others who need to stay ahead of this trend!